Anika Therapeutics | Omsætningsaktiver

Current Assets Lave om Dato
Arrowhead Research USD 237.9M 181.62M 2023-12
Halozyme Therapeutics USD 746.42M 132.58M 2023-12
Insmed USD 929.06M 2.49M 2023-12
Integra LifeSciences USD 1.06B 30.81M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Smith & Nephew USD 3.88B 22M 2023-06
Veracyte USD 285.62M 14.46M 2023-12
Xencor USD 623.16M 51.98M 2023-12



Anika Therapeutics Omsætningsaktiver - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - May 2024.